Search

everythinglearnresearchcommunity

for

Search:↓

Avicennia marina heartwood extract shows strong antioxidant potential for health benefits.

Leflunomide and anthralin may effectively treat severe alopecia areata.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Ascorbic acid derivatives improve drug delivery systems.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

A man with lung cancer had skin and eye side effects from erlotinib but continued treatment with symptom improvement.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

NSC167409 can effectively inhibit the virus causing hand, foot, and mouth disease.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

AVT is highly conserved and may have antimicrobial properties.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

MK-5108 is safe and shows potential against tumors, especially alone.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.